Obesity News and Research

Latest Obesity News and Research

Patients with diabetes, depression more likely to develop serious eye disease

Patients with diabetes who also suffer from depression are more likely to develop a serious complication known as diabetic retinopathy, a disease that damages the eye's retina, a five-year study finds.

29 Jul 2011

Muscle mass may influence risk for diabetes: Study

According to a new study greater muscle mass may reduce the odds of developing diabetes. There have been studies that show having less body fat reduces diabetes risk and that exercise can help too, but the new study by UCLA scientists suggests a link between higher muscle mass and a lower risk of diabetes.

29 Jul 2011

Stroke in pregnancy on the rise

According to latest reports the number of strokes among pregnant women and new mothers has risen to a new peak probably because more of them are obese and suffering from high blood pressure and heart disease.

29 Jul 2011

Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued in October 2010 by the U.S. Food and Drug Administration (FDA) regarding BYDUREON™ (exenatide extended-release for injectable suspension), an investigational medication for type 2 diabetes.

28 Jul 2011

Relative muscle mass inversely linked with insulin resistance and pre-diabetes

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that the greater an individual's total muscle mass, the lower the person's risk of having insulin resistance, the major precursor of type 2 diabetes.

28 Jul 2011

Study examines effect of unhealthy food outlets on adolescent junk food consumption

Got lots of fast food restaurants and other outlets that sell junk food in your neighborhood? Then your teen is more likely to nosh regularly on burgers and fries and wash them down with a soda.

28 Jul 2011

Roux-en-Y gastric bypass appears to reduce dietary fat intake

Roux-en-Y gastric bypass, the most common type of bariatric surgery in the United States, is currently considered the most effective therapy for morbid obesity.

28 Jul 2011

Noninvasive brain computer interface could turn thoughts into motion

"Brain cap" technology being developed at the University of Maryland allows users to turn their thoughts into motion. Associate Professor of Kinesiology José 'Pepe' L. Contreras-Vidal and his team have created a non-invasive, sensor-lined cap with neural interface software that soon could be used to control computers, robotic prosthetic limbs, motorized wheelchairs and even digital avatars.

28 Jul 2011

U.S. food labelling system has a positive impact

Around a sixth of fast food customers used calorie information and, on average, bought food with lower calories since the introduction of a labelling system in the US, says a new study published on bmj.com today.

28 Jul 2011

New study shows high prevalence of gout in the U.S.

A new study shows the prevalence of gout in the U.S. has risen over the last twenty years and now affects 8.3 million (4%) Americans.

28 Jul 2011

A healthier ‘Happy Meal’ on the way

McDonald’s Happy Meal, under the pressure from health advocates, will now become a little more healthy. The company announced Tuesday that it would replace more than halve the amount of French fries and add fruit to its popular children’s meal in an effort to reduce the overall calorie count by 20 percent. A toy will still come with each Happy Meal despite criticism that the trinkets, often with tie-ins to movies, foster a powerful connection between children and the often calorie-laden meals.

27 Jul 2011

Gut microflora may influence obesity treatments

Obesity in the United States is reaching ever more alarming proportions, posing a severe menace to public health and exacerbating a crisis in health care costs both domestically and worldwide.

27 Jul 2011

Less than 10% on a diet actually lose weight!

...

26 Jul 2011

Calorie counts on menus do help diners choose healthy

According to a latest review of the nutritional information on menu card scheme, putting calorie information on menus encourages healthy eating - but only in a limited way.

26 Jul 2011

Racal differences in breast cancer survival: Study

Black women are more likely to die from breast cancer than white women with obesity considered a significant factor. But a new study shows that that the cause of the difference does not lie in obesity alone. As a group, black women in the U.S. tend to be heavier than whites and researchers had thought that might explain why only 78 percent survive five years after diagnosis, compared to 90 percent of white women.

26 Jul 2011

Type 2 diabetes and obesity in pregnancy is a daunting duo: New research

Type 2 diabetes and obesity in pregnancy is a daunting duo, according to new research published this month in The Journal of Maternal-Fetal and Neonatal Medicine. The study shows that both conditions independently contribute to higher risks, opening the door to a wide range of pregnancy, delivery and newborn complications.

26 Jul 2011

When psoriasis strikes the famously beautiful

It appears that psoriasis spares none. Reality TV star Kim Kardashian has been reportedly diagnosed with the skin condition. Her condition was revealed on a recent episode of “Keeping Up with the Kardashians” on E!.

25 Jul 2011

Australian TGA approves GI Dynamics EndoBarrier Gastrointestinal Liner for type 2 diabetes and obesity

GI Dynamics, Inc., a company focused on the development and commercialization of effective, non-surgical approaches for the treatment of type 2 diabetes and obesity, today announced that the Australian Therapeutic Goods Administration (TGA) has approved the EndoBarrier® Gastrointestinal Liner for inclusion on the Australian Register of Therapeutic Goods (ARTG).

25 Jul 2011

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Baxter International Inc. announced today that the U.S. Food and Drug Administration has approved the subcutaneous administration of GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] for patients with primary immunodeficiency.

From Baxter International Inc. 25 Jul 2011

Eating location, food source impact daily energy intake for children

As childhood obesity rises and the American diet shifts towards increasing consumption of foods eaten or prepared outside of the home, concerns about the nutritional quality and the total consumption of such foods are also increasing.

25 Jul 2011

Obesity News and Research

Latest Obesity News and Research

Patients with diabetes, depression more likely to develop serious eye disease

Muscle mass may influence risk for diabetes: Study

Stroke in pregnancy on the rise

Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON

Relative muscle mass inversely linked with insulin resistance and pre-diabetes

Study examines effect of unhealthy food outlets on adolescent junk food consumption

Roux-en-Y gastric bypass appears to reduce dietary fat intake

Noninvasive brain computer interface could turn thoughts into motion

U.S. food labelling system has a positive impact

New study shows high prevalence of gout in the U.S.

A healthier ‘Happy Meal’ on the way

Gut microflora may influence obesity treatments

Less than 10% on a diet actually lose weight!

Calorie counts on menus do help diners choose healthy

Racal differences in breast cancer survival: Study

Type 2 diabetes and obesity in pregnancy is a daunting duo: New research

When psoriasis strikes the famously beautiful

Australian TGA approves GI Dynamics EndoBarrier Gastrointestinal Liner for type 2 diabetes and obesity

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Eating location, food source impact daily energy intake for children

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Obesity News and Research

Latest Obesity News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in